Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice

被引:0
作者
Iris Leinhase
Michal Rozanski
Denise Harhausen
Joshua M Thurman
Oliver I Schmidt
Amir M Hossini
Mohy E Taha
Daniel Rittirsch
Peter A Ward
V Michael Holers
Wolfgang Ertel
Philip F Stahel
机构
[1] Charité University Medical School,Department of Trauma and Reconstructive Surgery
[2] University of Colorado Health Sciences Center,Departments of Medicine and Immunology
[3] University of Michigan Medical School,Department of Pathology
[4] University of Colorado School of Medicine,Department of Orthopedic Surgery, Denver Health Medical Center
来源
Journal of Neuroinflammation | / 4卷
关键词
Traumatic Brain Injury; Alternative Pathway Complement; Traumatic Brain Injury Group; Neurological Severity Score; Traumatic Brain Injury Model;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 334 条
[21]  
Gasque P(2002)Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury J Neurotrauma 19 705-714
[22]  
Singhrao S(2004)Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist J Neuroimmunol 155 55-63
[23]  
Piddlesden SJ(2004)Neuroprotection from complement-mediated inflammatory damage Ann N Y Acad Sci 1035 147-164
[24]  
Maas AI(2005)Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection Ann N Y Acad Sci 1056 413-429
[25]  
Steyerberg EW(2005)Administration of vaccinia virus complement control protein shows significant cognitive improvement in a mild injury model Ann N Y Acad Sci 1056 450-461
[26]  
Murray GD(2006)Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury Exp Neurol 199 454-464
[27]  
Bullock R(2003)Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice J Cereb Blood Flow Metab 23 1070-1074
[28]  
Baethmann A(1999)Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci 22 397-402
[29]  
Marshall LF(1999)Development of C5a receptor antagonists IDrugs 2 686-693
[30]  
Teasdale GM(2006)Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration Faseb J 20 1407-1417